<p>Envestnet Asset Management Inc. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，第三季度其在 Corteva, Inc.（纽约证券交易所代码：CTVA - 免费报告）的持股增加了 5.9%。该公司在此期间额外购买了 119,759 股，持有的股票总数达到 2,138,576 股。Envestnet Asset Management Inc. 在最近的报告期末持有的 Corteva 股票约占 0.31%，价值 1.4464 亿美元。</p>
<ul>
<li>这三只股票刚刚被升级——并可能继续上涨</li>
</ul>
<p>其他对冲基金最近也调整了对该公司的持股。Ashton Thomas Private Wealth LLC 在第三季度将其在 Corteva 的持仓增加了 40.3%。Ashton Thomas Private Wealth LLC 目前持有 8,618 股该公司的股票，价值 583,000 美元，此前在上个季度额外购买了 2,476 股。Premier Path Wealth Partners LLC 在第三季度将其在 Corteva 的持股增加了 4.3%。Premier Path Wealth Partners LLC 目前持有 10,947 股该公司的股票，价值 740,000 美元，此前在此期间购买了 456 股。Compass Financial Services Inc 在第三季度购买了新的 Corteva 股票，价值约 34,000 美元。Physician Wealth Advisors Inc. 在第三季度将其在 Corteva 的持股增加了 85.1%。Physician Wealth Advisors Inc. 目前持有 498 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 229 股。最后，Simmons Bank 在第三季度将其在 Corteva 的持股增加了 3.8%。Simmons Bank 目前持有 40,515 股该公司的股票，价值 274 万美元，此前在此期间额外购买了 1,471 股。机构投资者持有该公司 81.54% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<p>CTVA 已成为多份研究分析报告的主题。富国银行将 Corteva 的目标价格从 77.00 美元上调至 85.00 美元，并在周四的研究报告中给予该股票 “超配” 评级。高盛集团重申了对 Corteva 的 “买入” 评级，并在周四的报告中给出了 88.00 美元的目标价格。华尔街 Zen 将 Corteva 的评级从 “买入” 下调至 “持有”，并在周六的研究报告中提到。花旗集团将 Corteva 的目标价格从 74.00 美元上调至 80.00 美元，并在周四的研究报告中给予该公司 “中性” 评级。最后，Zacks Research 在 1 月 22 日的研究报告中将 Corteva 的评级从 “持有” 上调至 “强烈买入”。两位股票研究分析师给予该股票 “强烈买入” 评级，十三位给予 “买入” 评级，六位给予 “持有” 评级。根据 MarketBeat 的数据，Corteva 目前的共识评级为 “适度买入”，平均目标价格为 82.37 美元。</p>
<ul>
<li>特朗普的人工智能推动可能使这三只农业股票受益</li>
</ul>
<p><strong>查看我们关于 Corteva 的最新研究报告</strong></p>
<h2>Corteva 股票上涨 0.2%</h2>
<p>纽约证券交易所代码：CTVA 周五开盘价为 72.63 美元。该公司的市值为 490.8 亿美元，市盈率为 45.97，PEG 比率为 1.84，贝塔值为 0.75。Corteva, Inc. 的 52 周低点为 53.40 美元，52 周高点为 77.41 美元。该公司的速动比率为 1.07，流动比率为 1.43，债务与股本比率为 0.07。该公司的 50 日移动平均线为 68.82 美元，200 日移动平均线为 68.42 美元。</p>
<ul>
<li>2025 年特朗普总统任期内受益的两只农业股票</li>
</ul>
<p>Corteva（纽约证券交易所代码：CTVA - 获取免费报告）最近于 2 月 3 日发布了季度财报。该公司报告每股收益（EPS）为 0.22 美元，符合共识预期的 0.22 美元。Corteva 的净利润率为 6.29%，股本回报率为 9.06%。该公司在本季度的收入为 39.1 亿美元，而分析师预期为 42.3 亿美元。去年同期，该公司每股收益为 0.32 美元。该公司本季度的收入同比下降了 1.7%。Corteva 将其 2026 财年的指导目标设定为每股收益 3.450-3.700 美元。整体来看，卖方分析师预计 Corteva, Inc. 本财年的每股收益为 2.96 美元。</p>
<h2>Corteva 宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 3 月 16 日支付。3 月 2 日的股东将获得 0.18 美元的分红。除息日期为 3 月 2 日。这相当于每年 0.72 美元的分红，收益率为 1.0%。Corteva 的分红支付比率（DPR）为 45.57%。</p>
<h2>Corteva 新闻汇总</h2>
<p>以下是本周影响 Corteva 的主要新闻故事：</p>
<ul>
<li>积极情绪：多家卖方机构上调目标价并维持看涨评级，显示分析师对长期上涨的信心：德意志银行上调至 90 美元（买入），沃尔夫研究上调至 86 美元（跑赢大盘），RBC 上调至 89 美元（跑赢大盘）。德意志银行上调沃尔夫研究上调 RBC 上调</li>
<li>积极情绪：经纪公司共识保持建设性（共识 “适度买入”），这支持了尽管短期噪音仍然存在的股票需求。共识适度买入</li>
<li>积极情绪：战略评论强调科迪华在全球农业和技术领导力中日益扩大的角色——对中期增长预期积极。科迪华扩展角色</li>
<li>中性情绪：分析师观点在各出版物中存在分歧——一些强调与许可和和解相关的长期上涨，而另一些则认为估值限制了短期收益。投资者应权衡催化剂时机。看涨案例分析分析师观点相互矛盾</li>
<li>中性情绪：技术分析文章警告关键结构测试——对交易者有用，但对基本面并不决定性；可能增加短期波动性。技术谨慎</li>
<li>消极情绪：第四季度业绩未达到收入预期（季节性时机和较弱的作物保护/种子需求）；收入未达预期和更大的亏损导致盘后抛售。这些运营失误是主要的短期阻力。第四季度收入未达预期盘后下跌</li>
<li>消极情绪：摩根大通将科迪华评级从增持下调至中性（ citing 估值/有限的短期上涨），这可能会冷却机构买家的动能。摩根大通下调</li>
<li>消极情绪：市场对收益未达预期（季节性时机）和混合指导因素的反应增加了短期不确定性，即使分析师主张长期上涨——预计日内波动性加大。季节性时机影响</li>
</ul>
<h2>关于科迪华</h2>
<p>（免费报告）</p>
<p>科迪华公司（Corteva, Inc）NYSE: CTVA 是一家独立的全球农业公司，成立于 2019 年中期，经过与道达尔杜邦（DowDuPont）农业业务的分离后成为一家上市公司。该公司专注于提供帮助农民提高生产力和管理作物健康的技术和产品。科迪华的运营结合了种子遗传学、作物保护化学品、数字工具和生物解决方案，以应对作物生产的整个周期。</p>
<p>核心业务活动包括种子遗传学和性状技术的研究与开发、作物保护产品（如除草剂、杀虫剂和杀真菌剂）的配方和销售，以及种子处理和生物制剂的开发。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比科迪华更好</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>你的银行账户不再安全</li>
<li>明天买这只股票？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNUVkE?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNUVkE"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在科迪华吗？</h2>
<p>在你考虑科迪华之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而科迪华并不在名单上。</p>
<p>虽然科迪华目前在分析师中获得适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

全球农业 ETF - Market Vectors

科迪华农业科技

全球农业 - First Trust

全球农产品股指数 ETF - iShares

农产品基金 - PowerShares

<p>Envestnet Asset Management Inc. 在第三季度将其在科迪华农业科技的持股增加了 5.9%，增持了 119,759 股，总持股达到 2,138,576 股，市值为 1.4464 亿美元。其他对冲基金也提高了他们的持仓。分析师对科迪华的评级不一，目标价格范围在 74 美元到 88 美元之间。该股票开盘价为 72.63 美元，市值为 490.8 亿美元。科迪华报告第四季度每股收益为 0.22 美元，与预期一致，并宣布季度股息为 0.18 美元，将于 3 月 16 日支付</p>

<p>Envestnet Asset Management Inc. raised its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 5.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,138,576 shares of the company's stock after buying an additional 119,759 shares during the period. Envestnet Asset Management Inc. owned about 0.31% of Corteva worth $144,640,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Envestnet Asset Management Inc. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，第三季度其在 Corteva, Inc.（纽约证券交易所代码：CTVA - 免费报告）的持股增加了 5.9%。该公司在此期间额外购买了 119,759 股，持有的股票总数达到 2,138,576 股。Envestnet Asset Management Inc. 在最近的报告期末持有的 Corteva 股票约占 0.31%，价值 1.4464 亿美元。</p>
</div><ul>
<li>These 3 Stocks Just Got Upgraded—and Could Keep Climbing</li>
</ul>
<div class="lb-trans"><ul>
<li>这三只股票刚刚被升级——并可能继续上涨</li>
</ul>
</div><p>Other hedge funds have also recently modified their holdings of the company. Ashton Thomas Private Wealth LLC grew its position in Corteva by 40.3% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 8,618 shares of the company's stock valued at $583,000 after acquiring an additional 2,476 shares during the last quarter. Premier Path Wealth Partners LLC boosted its stake in shares of Corteva by 4.3% during the third quarter. Premier Path Wealth Partners LLC now owns 10,947 shares of the company's stock valued at $740,000 after purchasing an additional 456 shares during the period. Compass Financial Services Inc bought a new position in shares of Corteva in the third quarter worth about $34,000. Physician Wealth Advisors Inc. grew its holdings in shares of Corteva by 85.1% in the third quarter. Physician Wealth Advisors Inc. now owns 498 shares of the company's stock worth $34,000 after purchasing an additional 229 shares during the last quarter. Finally, Simmons Bank increased its stake in Corteva by 3.8% in the 3rd quarter. Simmons Bank now owns 40,515 shares of the company's stock worth $2,740,000 after buying an additional 1,471 shares during the period. Institutional investors own 81.54% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金最近也调整了对该公司的持股。Ashton Thomas Private Wealth LLC 在第三季度将其在 Corteva 的持仓增加了 40.3%。Ashton Thomas Private Wealth LLC 目前持有 8,618 股该公司的股票，价值 583,000 美元，此前在上个季度额外购买了 2,476 股。Premier Path Wealth Partners LLC 在第三季度将其在 Corteva 的持股增加了 4.3%。Premier Path Wealth Partners LLC 目前持有 10,947 股该公司的股票，价值 740,000 美元，此前在此期间购买了 456 股。Compass Financial Services Inc 在第三季度购买了新的 Corteva 股票，价值约 34,000 美元。Physician Wealth Advisors Inc. 在第三季度将其在 Corteva 的持股增加了 85.1%。Physician Wealth Advisors Inc. 目前持有 498 股该公司的股票，价值 34,000 美元，此前在上个季度额外购买了 229 股。最后，Simmons Bank 在第三季度将其在 Corteva 的持股增加了 3.8%。Simmons Bank 目前持有 40,515 股该公司的股票，价值 274 万美元，此前在此期间额外购买了 1,471 股。机构投资者持有该公司 81.54% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>CTVA has been the topic of a number of research analyst reports. Wells Fargo &amp; Company upped their target price on shares of Corteva from $77.00 to $85.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday. The Goldman Sachs Group reiterated a &#34;buy&#34; rating and issued a $88.00 price target on shares of Corteva in a report on Thursday. Wall Street Zen cut Corteva from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday. Citigroup lifted their target price on Corteva from $74.00 to $80.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday. Finally, Zacks Research raised Corteva from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Corteva presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $82.37.</p>
<div class="lb-trans"><p>CTVA 已成为多份研究分析报告的主题。富国银行将 Corteva 的目标价格从 77.00 美元上调至 85.00 美元，并在周四的研究报告中给予该股票 “超配” 评级。高盛集团重申了对 Corteva 的 “买入” 评级，并在周四的报告中给出了 88.00 美元的目标价格。华尔街 Zen 将 Corteva 的评级从 “买入” 下调至 “持有”，并在周六的研究报告中提到。花旗集团将 Corteva 的目标价格从 74.00 美元上调至 80.00 美元，并在周四的研究报告中给予该公司 “中性” 评级。最后，Zacks Research 在 1 月 22 日的研究报告中将 Corteva 的评级从 “持有” 上调至 “强烈买入”。两位股票研究分析师给予该股票 “强烈买入” 评级，十三位给予 “买入” 评级，六位给予 “持有” 评级。根据 MarketBeat 的数据，Corteva 目前的共识评级为 “适度买入”，平均目标价格为 82.37 美元。</p>
</div><ul>
<li>How Trump’s AI Push Could Boost These 3 Agriculture Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>特朗普的人工智能推动可能使这三只农业股票受益</li>
</ul>
</div><p><strong>View Our Latest Research Report on Corteva</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Corteva 的最新研究报告</strong></p>
</div><h2>Corteva Trading Up 0.2%</h2>
<div class="lb-trans"><h2>Corteva 股票上涨 0.2%</h2>
</div><p>NYSE:CTVA opened at $72.63 on Friday. The stock has a market capitalization of $49.08 billion, a price-to-earnings ratio of 45.97, a PEG ratio of 1.84 and a beta of 0.75. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $77.41. The company has a quick ratio of 1.07, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a 50 day moving average of $68.82 and a 200 day moving average of $68.42.</p>
<div class="lb-trans"><p>纽约证券交易所代码：CTVA 周五开盘价为 72.63 美元。该公司的市值为 490.8 亿美元，市盈率为 45.97，PEG 比率为 1.84，贝塔值为 0.75。Corteva, Inc. 的 52 周低点为 53.40 美元，52 周高点为 77.41 美元。该公司的速动比率为 1.07，流动比率为 1.43，债务与股本比率为 0.07。该公司的 50 日移动平均线为 68.82 美元，200 日移动平均线为 68.42 美元。</p>
</div><ul>
<li>2 Agriculture Stocks To Benefit From a Trump Presidency in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>2025 年特朗普总统任期内受益的两只农业股票</li>
</ul>
</div><p>Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period in the previous year, the company earned $0.32 earnings per share. The business's revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Corteva（纽约证券交易所代码：CTVA - 获取免费报告）最近于 2 月 3 日发布了季度财报。该公司报告每股收益（EPS）为 0.22 美元，符合共识预期的 0.22 美元。Corteva 的净利润率为 6.29%，股本回报率为 9.06%。该公司在本季度的收入为 39.1 亿美元，而分析师预期为 42.3 亿美元。去年同期，该公司每股收益为 0.32 美元。该公司本季度的收入同比下降了 1.7%。Corteva 将其 2026 财年的指导目标设定为每股收益 3.450-3.700 美元。整体来看，卖方分析师预计 Corteva, Inc. 本财年的每股收益为 2.96 美元。</p>
</div><h2>Corteva Announces Dividend</h2>
<div class="lb-trans"><h2>Corteva 宣布分红</h2>
</div><p>The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 1.0%. Corteva's dividend payout ratio (DPR) is 45.57%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 3 月 16 日支付。3 月 2 日的股东将获得 0.18 美元的分红。除息日期为 3 月 2 日。这相当于每年 0.72 美元的分红，收益率为 1.0%。Corteva 的分红支付比率（DPR）为 45.57%。</p>
</div><h2>Corteva News Roundup</h2>
<div class="lb-trans"><h2>Corteva 新闻汇总</h2>
</div><p>Here are the key news stories impacting Corteva this week:</p>
<div class="lb-trans"><p>以下是本周影响 Corteva 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raiseWolfe Research raiseRBC raise</li>
<li>Positive Sentiment: Brokerage consensus remains constructive (consensus &#34;Moderate Buy&#34;), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy</li>
<li>Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role</li>
<li>Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysisConflicting analyst views</li>
<li>Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution</li>
<li>Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue missAfter‑hours fall</li>
<li>Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade</li>
<li>Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：多家卖方机构上调目标价并维持看涨评级，显示分析师对长期上涨的信心：德意志银行上调至 90 美元（买入），沃尔夫研究上调至 86 美元（跑赢大盘），RBC 上调至 89 美元（跑赢大盘）。德意志银行上调沃尔夫研究上调 RBC 上调</li>
<li>积极情绪：经纪公司共识保持建设性（共识 “适度买入”），这支持了尽管短期噪音仍然存在的股票需求。共识适度买入</li>
<li>积极情绪：战略评论强调科迪华在全球农业和技术领导力中日益扩大的角色——对中期增长预期积极。科迪华扩展角色</li>
<li>中性情绪：分析师观点在各出版物中存在分歧——一些强调与许可和和解相关的长期上涨，而另一些则认为估值限制了短期收益。投资者应权衡催化剂时机。看涨案例分析分析师观点相互矛盾</li>
<li>中性情绪：技术分析文章警告关键结构测试——对交易者有用，但对基本面并不决定性；可能增加短期波动性。技术谨慎</li>
<li>消极情绪：第四季度业绩未达到收入预期（季节性时机和较弱的作物保护/种子需求）；收入未达预期和更大的亏损导致盘后抛售。这些运营失误是主要的短期阻力。第四季度收入未达预期盘后下跌</li>
<li>消极情绪：摩根大通将科迪华评级从增持下调至中性（ citing 估值/有限的短期上涨），这可能会冷却机构买家的动能。摩根大通下调</li>
<li>消极情绪：市场对收益未达预期（季节性时机）和混合指导因素的反应增加了短期不确定性，即使分析师主张长期上涨——预计日内波动性加大。季节性时机影响</li>
</ul>
</div><h2>About Corteva</h2>
<div class="lb-trans"><h2>关于科迪华</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.</p>
<div class="lb-trans"><p>科迪华公司（Corteva, Inc）NYSE: CTVA 是一家独立的全球农业公司，成立于 2019 年中期，经过与道达尔杜邦（DowDuPont）农业业务的分离后成为一家上市公司。该公司专注于提供帮助农民提高生产力和管理作物健康的技术和产品。科迪华的运营结合了种子遗传学、作物保护化学品、数字工具和生物解决方案，以应对作物生产的整个周期。</p>
</div><p>Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.</p>
<div class="lb-trans"><p>核心业务活动包括种子遗传学和性状技术的研究与开发、作物保护产品（如除草剂、杀虫剂和杀真菌剂）的配方和销售，以及种子处理和生物制剂的开发。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Corteva</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>The day the gold market broke</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Buy this stock tomorrow?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比科迪华更好</li>
<li>新法律：国会批准数字美元的设立？</li>
<li>黄金市场崩溃的那一天</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>你的银行账户不再安全</li>
<li>明天买这只股票？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNUVkE" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CTVA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Corteva Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在科迪华吗？</h2>
</div><p>Before you consider Corteva, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑科迪华之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而科迪华并不在名单上。</p>
</div><p>While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然科迪华目前在分析师中获得适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Envestnet 资产管理公司购入了 119,759 股科迪华农业科技公司（Corteva, Inc.）的股票，股票代码为$CTVA